HTT and Huntington disease: To determine the effects of wig-1 knockdown on htt expression, wig-1 ASO was administered as a single striatal injection (75 μg) in 5 month old BACHD mice, a model of Huntington's disease, and compared with PBS or a control oligonucleotide.